➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Moodys
McKinsey
Medtronic
Colorcon

Last Updated: March 3, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for ADL5859

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug ADL5859?

ADL5859 is an investigational drug.

There have been 4 clinical trials for ADL5859. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2007.

The most common disease conditions in clinical trials are Arthritis, Peripheral Nervous System Diseases, and Neuralgia. The leading clinical trial sponsors are Cubist Pharmaceuticals LLC, Pfizer, and [disabled in preview].

Recent Clinical Trials for ADL5859
TitleSponsorPhase
Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the KneePfizerPhase 2
Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the KneeCubist Pharmaceuticals LLCPhase 2
Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral NeuropathyCubist Pharmaceuticals LLCPhase 2

See all ADL5859 clinical trials

Clinical Trial Summary for ADL5859

Top disease conditions for ADL5859
Top clinical trial sponsors for ADL5859

See all ADL5859 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Moodys
McKinsey
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.